Newsletter  |  Samstag, 24. März 2018, 22:52 Uhr


Über Diabetes

Praktische Hilfe
Diabetes und Vorsorge
Klinische Studien


gefördert durch:

Alberti KGMM. Screening and diagnosis of prediabetes: where are we headed? Diabetes. Obes Metab 2007; 9: 12-16

Arznei-Telegramm. Arzneimittelkursbuch. 2007/2008. AVI Berlin

Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. W.A. Scherbaum WA, Kerner W (Hg). Definition, Klassifikation und Diagnostik des Diabetes mellitus. 2005

Balion CM, Raina PS, Gerstein HC, Santaguida PL, Morrison KM, Booker L, Hunt DL. Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review. Clin Chem Lab Med 2007;45(9):1180–1185Bergmann A et al. A simplified Finish Diabetes risk score to predict type 2 Diabetes risk and disease evaluation in a German population. Horm Metab Res 2007; 39:677-682.

Diabetes Prevention Program Research Group (DPP). Reduction in the incidence of type 2 diabetes with lifestyle interventions or metformin. N Engl J Med 2002; 346: 393-403

Eborall H et al. Patients’ experiences of screening for type 2 diabetes: prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 2007; 335: 490

Engelgau M et al. Screening for type 2 diabetes. Diabetes Care 2000; 23: 1563-1580

Gillies CL et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007; 334: 299

Hamer M et al. Intake of fruit, vegetables, and antioxidants and risk of type 2 diabetes: systematic review and meta-analysis. J Hypertens 2007; 25: 2361-2369

Kerner W et al. Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie 2008; 3: Suppl 2, S131-S133

Löwel H et al. Das diabetesbedingte Herzinfarktrisiko in einer süddeutschen Bevölkerung: Ergebnisse der MONICA-Augsburg Studien 1985–1994. Diab Stoffw 1999; 8 (1): 11–21.

Manucci E et al. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2003; 40: 181-186

Mühlhauser I. Acarbose for type 2 diabetes prevention. The Lancet 2002;360:1516-1517

Norris SL et al. Long-term non-pharmacological weight loss interventions for adults with prediabetes (Review). Cochrane Database of Systematic Reviews 2005: Issue 2 Priebe MG et al. Whole grain foods for the prevention of type 2 diabetes mellitus (Review). Cochrane Database of Systematic Reviews 2008: Issue 1

Rathmann W et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-189

Schuppenies A et al. FINDRISK – Development of a questionnaire to estimate the risk of diabetes. Ernährungs-Umschau 2006;53:386.

The DREAM trial investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006; 368:1096-1105.

Tuomilehto et al. Prevention of type 2 Diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.

Uusitupa et al. Ten-year mortality and cardiovascular morbidity in the Finnish diabetes prevention study – secondary analysis of the randomized trial. PLoS ONE 4(5):e5656 doi:10.1371/journal.pone.0005656.

Van de Laar et al. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose (Review). Cochrane Database of Systematic Reviews 2006: Issue 4

Waugh N et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007; 11: 1-125

World Health Organisation (WHO). Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. 2006 WHO Document Production Services, Geneva, Switzerland

Darstellung zum Ausdrucken